Gentex Corporation [GNTX] has traded in a range of $19.48 to $31.27 in the last 1 year. As of this writing, the stock is at $27.14, saw in change for the day. To check whether the stock’s short-term amount has a thrust, its good to check stock’s recent movement. Over the last week, GNTX shares are -0.15% down with the monthly amount drift of 0.37% and seems well in a long time frame.
On 5, October 2020, RetiSpec Announces Partnership With Gentex To Commercialize Alzheimer’s Disease Detection Technology. According to news published on Yahoo Finance, RetiSpec Inc. announced today that it is partnering with Gentex Corporation (NASDAQ: GNTX) to engineer, manufacture and commercialize technology for the early detection of Alzheimer’s disease.
Analyst Birdseye View:
The most recent analyst activity for Gentex Corporation [NASDAQ:GNTX] stock was on June 30, 2020, when it was Resumed with a Buy rating from B. Riley FBR, which also raised its 12-month price target on the stock to $32. Before that, on July 27, 2020, KeyBanc Capital Markets Recapitulated an Overweight rating and elevated its amount target to $33. On June 01, 2020, Robert W. Baird Upgrade an Outperform rating and boosted its price target on this stock from $27 to $32. On April 15, 2020, Goldman Initiated a Sell rating and increased its price target to $19. On January 06, 2020, Jefferies Upgrade a Buy rating and increased its price target to $37. On October 16, 2019, Guggenheim Initiated a Buy rating and boosted its amount on this stock to $29. On February 05, 2019, Longbow Downgrade a Neutral rating. On December 04, 2018 Jefferies Initiated a Hold rating and elevated its amount target to $24.
In the past 52 weeks of trading, this stock has oscillated between a low of $19.48 and a peak of $31.27. Right now, the middling Wall Street analyst 12-month amount mark is $33.00. At the most recent market close, shares of Gentex Corporation [NASDAQ:GNTX] were valued at $27.14. According to the average price forecast, investors can expect a potential return of 15.15%.
Gentex Corporation [NASDAQ:GNTX] most recently reported quarterly sales of 229.93 billion, which represented growth of -75.50%. This publicly-traded organization’s revenue is $316,462 per employee, while its income is $71,443 per employee. This company’s Gross Margin is currently 34.00%, its Operating Margin is 21.00%, its Pretax Margin is +26.92, and its Net Margin is +22.58. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at 19.59, 22.09, 25.71 and 22.09 respectively.
Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 26.93 points at 1st support level, the second support level is making up to 26.71. But as of 1st resistance point, this stock is sitting at 27.52 and at 27.89 for 2nd resistance point.
Gentex Corporation [GNTX] reported its earnings at $0.02 per share in the fiscal quarter closing of 6/29/2020. The Analysts for Wall Street were expecting to report its earnings at $0.12/share signifying the difference of -0.1 and -83.30% surprise value. Comparing the previous quarter ending of 3/30/2020, the stated earnings were $0.36 calling estimates for $0.34/share with the difference of 0.02 depicting the surprise of 5.90%.
Important Ratio’s To Watch
Meanwhile, turning our focus to liquidity, the Current Ratio for Gentex Corporation [NASDAQ:GNTX] is 3.90. Likewise, the Quick ratio is also the same, showing Cash ratio at 2.54. Now if looking for a valuation of this stock’s amount to sales ratio it’s 3.95, it’s amount to book ratio is 3.76 and showing 22.94 of P/E (TTM) ratio.
The most recent insider trade was by Downing Steven R, President and CEO, and it was the sale of 6000.0 shares on Sep 30. Nash Kevin C, the Chief Financial Officer, completed a sale of 3000.0 shares on Sep 30. On Sep 02, Downing Steven R, President and CEO, completed a sale of 23700.0 shares.